Fact CheckerSign in

NCT06299683Recruiting

Pain Type and Interstitial Cystitis/Bladder Pain Syndrome Treatment

Mechanistic-Based Treatment of Interstitial Cystitis/Bladder Pain Syndrome

Source: ClinicalTrials.gov · Last updated 21 Jan 2026

Brief summary (registry, in English)

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a severe pain condition affecting 3-8 million people in the United States lacking treatments that work. Emotional suffering is common in IC/BPS and known to make physical symptoms worse, and studies show patient sub-groups respond differently to treatment. Individuals with IC/BPS have distinct subgroups, or "phenotypes," largely characterized by the distribution of pain throughout the body. Supported by our preliminary evidence, the overall goal of this project is to assess how IC/BPS phenotype may affect response to two different therapies often given without regard to patient phenotype, pelvic floor physical therapy (PT) and cognitive-behavioral therapy (CBT) for IC/BPS.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
220 (estimated)
First submitted
29 Feb 2024
Start date
1 May 2024
Primary completion date
5 Apr 2027
Lead sponsor
Vanderbilt University Medical Center
NCT number
NCT06299683

What you commit to

  • Study type: Interventional
  • Planned participants: 220
  • From 1 May 2024 to the primary completion date, 5 Apr 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Comorbid neurological conditions including spinal cord injury or systematic neurologic illnesses, or central nervous system diseases such as brain tumor or stroke;
  • Current or history of diagnosis of primary psychotic or major thought disorder within the past five years;
  • Hospitalization for psychiatric reasons other than suicidal ideation, homicidal ideation, and/or PTSD (within the past 5 years);
  • Psychiatric or behavioral conditions in which symptoms are unstable or severe (e.g. current delirium, mania, psychosis, active suicidal ideation, homicidal ideation, substance abuse dependency) reported within the past six months;
  • Currently being treated for cancer;
  • Cancer-related pain;

Other

  • Non-English speaking;
  • Presenting symptoms at time of screening that would interfere with participation, specifically active suicidal ideation with intent to harm oneself or active delusional or psychotic thinking;
  • Difficulties or limitations communicating over the telephone or via teleconferencing systems;
  • Any planned life events that would interfere with participating in the key elements of the study;
  • Any major active medical issues that could preclude participation;
  • Currently pregnant;
  • Recently or actively participating in treatment similar to those being investigated (e.g. individual psychotherapy or pelvic floor pt).

Who the study is looking for

  • 18 years of age or older;
  • Diagnosis of IC/BPS as indicated by structured assessments;
  • Capable of giving written informed consent;
  • Able to enroll for the duration of the study period;

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Vanderbilt Urology Cool Springs
Coordinator of this site? Confirm its status
FranklinUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.